Before you continue to ppPLUS

Cookies

ppPLUS use cookies essential for this site to function well. Learn about our use of cookies, and collaboration with selected social media and trusted analytics partners here.

Privacy & Terms and Conditions

Please review our Privacy Policy and Terms & Conditions, before you start using ppPLUS.

Entity Shareholding

: Wacker Biotech B.V.

Shareholder: Wacker Chemicals Finance B.V.
Scenario: SS | Default Shareholder Scenario
Percentage: 100.00%
From: 06/2018
To: 12/2050
Consolidation: U
Multiple Shareholders
Document: https://www.wacker.com/cms/media/en/asset/about_wacker/wacker_at_a_glance/annual_report/annual_report_21.pdf
Description: With the takeover of SynCo Bio Partners B.V. in Amsterdam, the Netherlands, in 2018 Wacker Chemie AG strengthened its pharmaceutical protein business and expanded its portfolio.

System Info

User: Braun, Uwe
Modified: 11/1/2022 2:03 PM
Added: 11/1/2022 1:11 PM